BackNgm Biopharmaceuticals Overview

Ngm Biopharmaceuticals Cost of Revenue

Cost of Revenue analysis for NGM.

Quarterly Cost of Revenue

$518000.00

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$3.26M

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)